🇺🇸 FDA
Pipeline program

19(T2)28z1xx CAR T cells

20-167

Phase 1 small_molecule active

Quick answer

19(T2)28z1xx CAR T cells for Diffuse Large B Cell Lymphoma is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Diffuse Large B Cell Lymphoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials